Biocon Ltd. — Major Shareholding Notification 2020

Apr 22, 2020

Ms. Kiran Mazumdar Shaw Glenmore, No. 58 Goolimangala Village, Sarjapur Hobli, Anekal Taluk, Bengaluru- 562106, Karnataka

April 9, 2020

To, The Manager Listing The BSE Limited, Corporate Service Department Floor 25, P J Towers. Dalal Street, Mumbai 400 001 Scrip Code: 532523

To, The Manager Listing The National Stock Exchange of India Limited Corporate Communication Department Exchange Plaza, Bandra - Kurla Complex. Bandra (East), Mumbai- 400 051 Scrip Symbol: BIOCON

To, Biocon Limited 20^th KM, Hosur Road. Electronic City, Bengaluru Karnataka - 560 100

Sub: Annual Disclosure under Regulation 30(1) and 30(2) of the SEBI (Substantial Acquisition of Shares and Takeover) Regulation, 2011

Dear Sir/Madam,

This is with reference to the disclosure required under Regulation 30(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 ("Takeover Regulations") regarding aggregate shareholding and voting rights held by the promoter(s), member of promoter group and PAC with them as of the March 31, 2020.

We are enclosing herewith the said disclosures as on March 31, 2020 relating to Biocon Limited in the prescribed format.

Request to kindly take this intimation on record.

Yours faithfully,

$\mu$ $\mu$

Ms. Kiran Mazumdar Shaw Promoter

Enclosed: Disclosure under regulation 30(1) & 30(2) of SEBI (SAST) Regulation, 2011 Email to: BSE: corp.relations@bseindia.com NSE: takeover@nse.co.in

Disclosures under Regulation 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers)
Regulations, 2011 Rove A. Dotails of Shoroholdin

	Part-A- Details of Shareholding
1.	Name of the Target Company (TC)	Biocon Limited
2.	Name(s) of the Stock Exchange(s)	Bombay Stock Exchange Limited (BSE)
	where the shares of the TC are listed	National Stock Exchange of India Limited (NSE)
З.	Particulars of the shareholder(s):
а.	Name of person(s) together with
	Person Acting in Concert (PAC)
	whose total holding (including that in
	the form of shares, warrants,
	convertible securities and any other
	instrument that would entitle the
	holder to receive shares in the TC) is
	more than 25% of the voting rights
	of the TC.
	or
	b. Name(s) of promoter(s), member of	Promoters:
	the promoter group and PAC with	1. Ms. Kiran Mazumdar Shaw
	him.	2. Mr. John Shaw
		3. M\s. Glentec International Promoter Group:
		1. Mrs. Yamani R Mazumdar
		2. Prof. Ravi R Mazumdar & Catherine Patricia Rosenberg
		3. Mr. Dev Mazumdar
4.	Particulars of the shareholding of	Number of shares		% w.r.t. total	% of total
	person(s) mentioned at (3) above			share /voting	diluted
				capital	share/vot
				wherever	ing capital
				applicable	of TC (**)
	As on March 31 st of the year, holding of.
·a)	Shares	Kiran Mazumdar Shaw	47,57,25,384	39.64	ΝA.
		John Shaw	84,45,348	0.70	NA
		Glentec International	23,72,11,164	19.77	NA.
		Yamani R Mazumdar	13,00,212	0.11	NÄ
		Ravi R Mazumdar	48,15,084	0.40	NA
		Dev Mazumdar	5,18,484	0.04	NA ®
Voting Rights (otherwise than by shares)		NA	NA	NA	NΑ
	Warrants,	NA	NA	ŃΑ	NA.
	Convertible Securities	NA.	NA	NA	ΝA.
Any other instrument that would entitle
	the holder to receive shares in	NA	NA	NA	NA
	Total		72,80,15,676	60.67	NA

---

Part-B***

Name of the Target Company: Biocon Limited

Name(s) of the person and Persons Acting in Concert (PAC) with the person	Whether the person belongs to Promoter/Promoter group
Kiran Mazumdar Shaw	Promoter
John Shaw	Promoter
Glentec International	Promoter
Yamani R Mazumdar	Promoter group
Ravi R Mazumdar	Promoter group
Dev Mazumdar	Promoter group

$\mu$

Kiran Mazumdar Shaw Promoter

April 9, 2020

Note:

1. In case of promoter(s) making disclosure under regulation 30(2), no additional disclosure under regulation 30(1) is required.

(**) Diluted share/voting capital means the total number of shares in the TC assuming full conversion of the outstanding convertible securities/warrants into equity shares of the TC.

(***) Part-B shall be disclosed to the Stock Exchanges but shall not be disseminated.